Security record · archived quarter
IQV
IQVIA Holdings Inc. · Healthcare · Medical - Diagnostics & Research
20Tracked holders
—Δ holders
21.58MShares held
$4.56BReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 166 | +9 | 122.80M | $23.68B | +12 | −2 |
| Q1 2026 | 159 | -11 | 122.65M | $21.04B | +3 | −15 |
| Q4 2025 | 169 | +1 | 132.77M | $29.93B | +3 | −1 |
| Q3 2025 | 26 | -1 | 77.42M | $14.69B | +1 | −3 |
| Q2 2025 | 25 | +2 | 68.72M | $10.83B | +2 | — |
| Q1 2025 | 20 | -1 | 30.89M | $5.44B | — | −1 |
| Q4 2024 | 21 | +1 | 31.11M | $6.11B | +1 | — |
| Q3 2024 | 19 | -1 | 19.49M | $4.61B | +1 | −2 |
| Q2 2024 | 20 | — | 21.58M | $4.56B | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 10.67M | — | $2.26B | 3.8% | n/c | 1 | SEC ↗ |
| 2 | Harris Associates (Oakmark) ✦ | 10.67M | — | $2.26B | 3.8% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 4.22M | — | $890.27M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 4.22M | — | $890.27M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.62M | — | $343.42M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 1.62M | — | $343.42M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.62M | — | $343.42M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 1.62M | — | $342.81M | 0.1% | n/c | 1 | SEC ↗ |
| 9 | Capital World Investors ✦ | 665.93K | — | $140.80M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 579.82K | — | $122.60M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 579.82K | — | $122.60M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 333.95K | — | $70.61M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | PRIMECAP Management ✦ | 325.18K | — | $68.76M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 323.91K | — | $68.49M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 313.09K | — | $66.20M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 313.09K | — | $66.20M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 268.55K | — | $56.78M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 268.55K | — | $56.78M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 168.80K | — | $35.69M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Millennium Management ✦ | 131.30K | — | $27.76M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 90.69K | — | $19.18M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 90.69K | — | $19.18M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 90.69K | — | $19.18M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 90.69K | — | $19.18M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Marshall Wace ✦ | 77.61K | — | $16.41M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Marshall Wace ✦ | 77.61K | — | $16.41M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Duquesne Family Office ✦ | 60.36K | — | $12.76M | 0.5% | n/c | 1 | SEC ↗ |
| 28 | Markel Group ✦ | 58.73K | — | $12.42M | 0.1% | n/c | 1 | SEC ↗ |
| 29 | Gotham Asset Management ✦ | 32.76K | — | $6.93M | 0.1% | n/c | 1 | SEC ↗ |
| 30 | Fisher Asset Management ✦ | 7.06K | — | $1.49M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Bridgewater Associates ✦ | 968 | — | $204,674 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,061 holders, 150.48M shares, $24.99B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API